TrialJournal of the American Academy of Dermatology2017

A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.

Stefan G Vanderweil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.